SYNTHESIS AND PLATELET-ACTIVATING-FACTOR (PAF)-ANTAGONISTIC ACTIVITIES OF 1,4-DISUBSTITUTED PIPERAZINE DERIVATIVES

被引：0
|
作者：
FUKUSHI, H
MABUCHI, H
ITOH, K
TERASHITA, Z
NISHIKAWA, K
SUGIHARA, H
机构：
[1] TAKEDA CHEM IND LTD, PHARMACEUT RES LABS 2, YODOGAWA KU, OSAKA 532, JAPAN
[2] TAKEDA CHEM IND LTD, PHARMACEUT RES LABS 3, YODOGAWA KU, OSAKA 532, JAPAN
[3] TAKEDA CHEM IND LTD, DIV PHARMACEUT RES, OSAKA 532, JAPAN
来源：
CHEMICAL & PHARMACEUTICAL BULLETIN | 1994年 / 42卷 / 03期
关键词：
PAF ANTAGONIST; STRUCTURE ACTIVITY RELATIONSHIP; 1,4-DISUBSTITUTED PIPERAZINE; 1-(6-METHOXY-3,4-DIHYDRO-2-NAPHTHOYL)-4-(3,4,5-TRIMETHOXYBENZYL)PIPERAZINE; 1-(2,3-DIMETHOXY-6,7-DIHYDRO-5H-BENZOCYCLOHEPTEN-8-YLCARBONYL)-4-(3,4,5-TRIMETHOXYBENZOYL)PIPERAZINE;
D O I：
暂无
中图分类号：
R914 [药物化学];
学科分类号：
100701 ;
摘要：
During the screening of novel platelet-activating factor (PAF) antagonists, we found that 1-(6-methoxy-3,4-dihydro-2-naphthoyl)-4-(3,4,5-trimethoxybenzyl)piperazine and its 4-(3,4,5-trimethoxybenzoyl)piperazine derivatives (1b, 2b) exerted in vitro and in vivo PAF-antagonistic activities. Modifications of the 1-acyl group, the substituent at the 4-position and the piperazine ring of 1a and 2b were examined and from this series 1-(2,3-dimethoxy-6,7-dihydro-5H-benzocyclohepten-8-ylcarbonyl)-4-(3,4,5-trimethoxybenzoyl)piperazine (2g) was found to be one of the most potent PAF antagonists.
引用
收藏
页码：541 / 550
页数：10
相关论文
共 50 条
  • [31] PLATELET-ACTIVATING-FACTOR (PAF) AND RELATED LIPID DERIVATIVES IN THE FETAL BRAIN DURING ISCHEMIA
    YAVIN, E
    KUNIEVSKY, B
    HOPHY, M
    GLUZMAN, S
    GREEN, P
    GIL, S
    JOURNAL OF NEUROCHEMISTRY, 1994, 63 : S23 - S23
  • [32] Antiarrhythmic properties of some 1,4-disubstituted piperazine derivatives with α1-adrenoceptor affinities
    Kubacka, Monika
    Mogilski, Szczepan
    Filipek, Barbara
    Marona, Henryk
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2013, 720 (1-3) : 237 - 246
  • [33] CARDIOVASCULAR AND PULMONARY ACTIVITY OF PLATELET-ACTIVATING-FACTOR (PAF-ACETHER) AND ITS DERIVATIVES
    BERTI, F
    FERRI, V
    PALLAVICINI, M
    PRETOLANI, M
    TREMOLI, E
    VALOTI, E
    VILLA, L
    PHARMACOLOGICAL RESEARCH COMMUNICATIONS, 1986, 18 (06): : 557 - 562
  • [34] Synthesis, pharmacological properties and SAR of new 1,4-disubstituted piperazine derivatives with hypnotic-sedative activity
    Chilmonczyk, Z
    Mazgajska, M
    Chojnacka-Wójcik, E
    Tatarczynska, E
    Klodzinska, A
    Ulman, M
    POLISH JOURNAL OF CHEMISTRY, 2004, 78 (08) : 1027 - 1037
  • [35] Synthesis and Antimalarial Activity of 1,4-Disubstituted Piperidine Derivatives
    Seck, Rokhyatou
    Gassama, Abdoulaye
    Cojean, Sandrine
    Cave, Christian
    MOLECULES, 2020, 25 (02):
  • [36] PLATELET-ACTIVATING-FACTOR (PAF)-INDUCED CHEMOTAXIS AND PAF BINDING TO HUMAN EOSINOPHILS
    FUKUDA, T
    NUMAO, T
    AKUTSU, I
    MAKINO, S
    JOURNAL OF LIPID MEDIATORS, 1992, 5 (02): : 145 - 149
  • [37] STUDY OF PLATELET-ACTIVATING-FACTOR (PAF) LEVELS AND PAF ACETYLHYDROLASE (AH) ACTIVITIES IN PATIENTS WITH PRIMARY GLOMERULONEPHRITIS (PGN)
    IATROU, C
    MOUSTAKAS, G
    ANTONOPOULOU, S
    DEMOPOULOS, CA
    ZIROGIANNIS, P
    JOURNAL OF LIPID MEDIATORS AND CELL SIGNALLING, 1994, 10 (1-2): : 117 - 118
  • [38] EXISTENCE OF ENDOGENOUS INHIBITORS OF PLATELET-ACTIVATING-FACTOR (PAF) WITH PAF IN RAT UTERUS
    NAKAYAMA, R
    YASUDA, K
    SAITO, K
    JOURNAL OF BIOLOGICAL CHEMISTRY, 1987, 262 (27) : 13174 - 13179
  • [39] PLATELET-ACTIVATING-FACTOR (PAF) AND LYSO-PAF IN INFLAMED HUMAN SKIN
    BARR, RM
    JUDGE, M
    MALLET, AI
    KOBZABLACK, A
    BARLOW, R
    GREAVES, MW
    AGENTS AND ACTIONS, 1994, 41 : C260 - C261
  • [40] MONOCLONAL ANTIIDIOTYPIC ANTIBODIES TO PLATELET-ACTIVATING-FACTOR (PAF) AND THEIR INTERACTION WITH PAF RECEPTORS
    WANG, CJ
    TAI, HH
    JOURNAL OF BIOLOGICAL CHEMISTRY, 1991, 266 (19) : 12372 - 12378
12345